Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology Awards Its 7th Annual Clinical Pharmacology Research Award
Tokyo, Japan (June 20, 2014) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Kiyoshi Morita), has awarded its 7th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.
Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation. Innovative research projects with expectations for future development are eligible for the award.
The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 11, 2014.
*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research, overseas studies for Japanese researchers, and international collaborations in Asia.
Recipients of the 7th Japan Research Foundation for Clinical Pharmacology Research Award
Department of Periodontology
School of Dental Medicine
The establishment and safety verification of controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel with new periodontal regeneration
Department of Surgery
Graduate School of Medicine
Evaluation of chemokine receptors inhibition for the prevention of colon cancer metastasis
Department of Organ Network and Metabolism Graduate School of Medical and Dental Sciences
Tokyo Medical and Dental University
Development of novel therapeutic strategies for non-alcoholic steatohepatitis using an unique mouse model
Laboratory of Pharmacotherapy of Life-style Related Diseases
Graduate School of Pharmaceutical Sciences
Prediction of inter-individual difference in drug metabolism :
Functional characterization of 32 CYP2C9 allelic variants using warfarin
Department of Hospital Pharmacy Hamamatsu University School of Medicine
Inosine 5’-monophosphate dehydrogenase activity in